Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Depreciation and Depletion (2021 - 2022)

Historic Depreciation and Depletion for Rani Therapeutics Holdings (RANI) over the last 2 years, with Q4 2022 value amounting to $126000.0.

  • Rani Therapeutics Holdings' Depreciation and Depletion rose 862.07% to $126000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $500000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.0 million for FY2024, which is 2500.0% up from last year.
  • Per Rani Therapeutics Holdings' latest filing, its Depreciation and Depletion stood at $126000.0 for Q4 2022, which was up 862.07% from $141000.0 recorded in Q3 2022.
  • Rani Therapeutics Holdings' Depreciation and Depletion's 5-year high stood at $141000.0 during Q3 2022, with a 5-year trough of $111000.0 in Q1 2022.